Research News from September 5, 2018
advertisement
- Innate immune activity as a predictor of persistent insulin secretion and association with responsiveness to CTLA4-Ig treatment in recent-onset type 1 diabetes.
- Therapies to Suppress β Cell Autoimmunity in Type 1 Diabetes. Free full text available in HTML and PDF formats.
- Deletion of the glucagon receptor gene before and after experimental diabetes reveals differential protection from hyperglycemia.